The field of microbiology has been transformed by the development of sequencing technology, which allows for the identification of microbial compositions in samples without the need for traditional microbiological culture. Next-generation sequencing (NGS) has emerged as a powerful diagnostic tool, enabling faster and more accurate results.

MGI offers a Microorganism Sequencing Product Portfolio that utilizes data generated by an independent high-throughput sequencing platform, an automated sample preparation system, self-developed compatible reagents, and a rapid identification system for microorganisms.

This portfolio allows for fast, accurate and comprehensive high-throughput sequencing of unknown microorganisms, providing reliable references for microorganism identification. Users have the flexibility to choose the appropriate hardware devices, compatible reagent kits, and data processing system based on their specific needs.